<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Endocrinol (Lausanne)</journal-id><journal-id journal-id-type="iso-abbrev">Front Endocrinol (Lausanne)</journal-id><journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id><journal-title-group><journal-title>Frontiers in Endocrinology</journal-title></journal-title-group><issn pub-type="epub">1664-2392</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29493662</article-id><article-id pub-id-type="pmc">5826954</article-id><article-id pub-id-type="doi">10.3389/fendo.2018.00050</article-id><article-categories><subj-group subj-group-type="heading"><subject>Endocrinology</subject><subj-group><subject>Correction</subject></subj-group></subj-group></article-categories><title-group><article-title>Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nystr&#x000f6;m</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/96320"/></contrib><contrib contrib-type="author"><name><surname>Santos-Pardo</surname><given-names>Irene</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/523414"/></contrib><contrib contrib-type="author"><name><surname>Hedberg</surname><given-names>Fredric</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wardell</surname><given-names>Johan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Witt</surname><given-names>Nils</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/462547"/></contrib><contrib contrib-type="author"><name><surname>Boj&#x000f6;</surname><given-names>Leif</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nilsson</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jendle</surname><given-names>Johan</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Clinical Science and Education, Karolinska Institutet, S&#x000f6;dersjukhuset</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country></aff><aff id="aff2"><sup>2</sup><institution>Institution of Medical Sciences, &#x000d6;rebro University</institution>, <addr-line>&#x000d6;rebro</addr-line>, <country>Sweden</country></aff><aff id="aff3"><sup>3</sup><institution>Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country></aff><aff id="aff4"><sup>4</sup><institution>Central Hospital</institution>, <addr-line>Karlstad</addr-line>, <country>Sweden</country></aff><aff id="aff5"><sup>5</sup><institution>Clinical Epidemiology and Biostatistics, School of Medical Sciences, &#x000d6;rebro University</institution>, <addr-line>&#x000d6;rebro</addr-line>, <country>Sweden</country></aff><author-notes><fn fn-type="edited-by"><p>Edited and Reviewed by: Frontiers in Endocrinology Editorial Office, Frontiers, Switzerland</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Thomas Nystr&#x000f6;m, <email>thomas.nystrom@sll.se</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Diabetes, a section of the journal Frontiers in Endocrinology</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>50</elocation-id><history><date date-type="received"><day>31</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>05</day><month>2</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Nystr&#x000f6;m, Santos-Pardo, Hedberg, Wardell, Witt, Cao, Boj&#x000f6;, Nilsson and Jendle.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Nystr&#x000f6;m, Santos-Pardo, Hedberg, Wardell, Witt, Cao, Boj&#x000f6;, Nilsson and Jendle</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><related-article id="d35e224" related-article-type="corrected-article" xlink:href="29184539" ext-link-type="pubmed" journal-id="Front Endocrinol" journal-id-type="nlm-ta" vol="8" page="325">A corrigendum on <article-title>Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study</article-title> by Nystr&#x000f6;m T, Santos-Pardo I, Hedberg F, Wardell J, Witt N, Cao Y, et al. Front Endocrinol (2017) 8:325. doi: <object-id>10.3389/fendo.2017.00325</object-id></related-article><kwd-group><kwd>longitudinal functional reserve index</kwd><kwd>liraglutide</kwd><kwd>subclinical heart failure</kwd><kwd>tissue Doppler echocardiography</kwd><kwd>type 2 diabetes</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><equation-count count="0"/><ref-count count="0"/><page-count count="1"/><word-count count="371"/></counts></article-meta></front><body><p>One of the authors name, Irene Santos-Pardo, was misspelled in the published manuscript (as Irene Padro Santos). The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.</p><p>The original article was updated.</p><sec id="S1"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body></article>